| scholarly article | Q13442814 |
| P50 | author | Jens Staal | Q37834573 |
| Steven Van Gucht | Q87609328 | ||
| P2093 | author name string | R Beyaert | |
| M Baens | |||
| M Romano | |||
| C Libert | |||
| M Kalai | |||
| A Hamouda | |||
| K Lemeire | |||
| L Verstrepen | |||
| V Suin | |||
| E Kip | |||
| H G Tima | |||
| P2860 | cites work | Estimating the global burden of endemic canine rabies | Q21090117 |
| Ambivalent role of the innate immune response in rabies virus pathogenesis | Q24300579 | ||
| Transmission dynamics and prospects for the elimination of canine rabies | Q27331839 | ||
| Structural analysis of phenothiazine derivatives as allosteric inhibitors of the MALT1 paracaspase | Q27685382 | ||
| 5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
| Differential Requirement for Malt1 in T and B Cell Antigen Receptor Signaling | Q28505229 | ||
| Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase | Q28591729 | ||
| Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis | Q29615108 | ||
| Rabies | Q31165356 | ||
| Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice | Q32091319 | ||
| Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis. | Q33958556 | ||
| Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system | Q33984263 | ||
| T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. | Q34174201 | ||
| Local nitric oxide production in viral and autoimmune diseases of the central nervous system | Q34209628 | ||
| Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. | Q34211312 | ||
| Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs | Q34297166 | ||
| Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation | Q34346617 | ||
| Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation | Q34441762 | ||
| Microglia in human immunodeficiency virus-associated neurodegeneration. | Q34963796 | ||
| Immune responses to RNA-virus infections of the CNS. | Q35140815 | ||
| NF-κB signaling pathways regulated by CARMA family of scaffold proteins | Q35347919 | ||
| Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor | Q35546855 | ||
| Neuronal dysfunction and death in rabies virus infection | Q36086332 | ||
| In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases | Q36214276 | ||
| Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice | Q36424030 | ||
| Isolation and Flow Cytometric Analysis of Immune Cells from the Ischemic Mouse Brain | Q36788361 | ||
| Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1 | Q36830073 | ||
| Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies | Q36988095 | ||
| Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. | Q37097294 | ||
| Immune evasion, a critical strategy for rabies virus. | Q37218920 | ||
| Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. | Q37348438 | ||
| The roles of chemokines in rabies virus infection: overexpression may not always be beneficial | Q37410626 | ||
| Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies | Q37664750 | ||
| Impact of caspase-1/11, -3, -7, or IL-1β/IL-18 deficiency on rabies virus-induced macrophage cell death and onset of disease. | Q37682941 | ||
| MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo | Q37699271 | ||
| Evasive strategies in rabies virus infection. | Q37877950 | ||
| Rabies virus clearance from the central nervous system. | Q37877951 | ||
| From MALT lymphoma to the CBM signalosome: three decades of discovery | Q37900457 | ||
| The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction | Q37915262 | ||
| MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression | Q38495157 | ||
| Targeting MALT1 Proteolytic Activity in Immunity, Inflammation and Disease: Good or Bad? | Q38703574 | ||
| CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection | Q38788570 | ||
| Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL. | Q39226671 | ||
| The type I interferon response bridles rabies virus infection and reduces pathogenicity | Q39497376 | ||
| Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. | Q39578252 | ||
| Failure to thrive, wasting syndrome, and immunodeficiency in rabies: a hypophyseal/hypothalamic/thymic axis effect of rabies virus | Q39618245 | ||
| The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. | Q40211782 | ||
| Human rabies: clinical aspects, pathogenesis, and potential therapy. | Q40595402 | ||
| Correlation of inducible nitric oxide synthase (iNOS) inhibition with TNF-α, caspase-1, FasL and TLR-3 in pathogenesis of rabies in mouse model | Q40862930 | ||
| The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells | Q41522425 | ||
| Mucosa-associated lymphoid tissue lymphoma translocation 1 as a novel therapeutic target for rheumatoid arthritis | Q41717303 | ||
| Microglia, seen from the CX3CR1 angle | Q43226619 | ||
| Pathogenesis of experimental rabies in mice: an immunohistochemical study | Q43460491 | ||
| Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration | Q44055767 | ||
| Parkinson disease: mechanisms of cell death | Q44400386 | ||
| Conditional gene targeting in macrophages and granulocytes using LysMcre mice. | Q44554898 | ||
| The histopathogenesis of paralytic rabies in six-week-old C57BL/6J mice following inoculation of the CVS-11 strain into the right triceps surae muscle | Q45133551 | ||
| A non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus | Q45252583 | ||
| The effect of selected molecules influencing the detrimental host immune response on a course of rabies virus infection in a murine model. | Q45324632 | ||
| In situ apoptosis of adaptive immune cells and the cellular escape of rabies virus in CNS from patients with human rabies transmitted by Desmodus rotundus | Q45369680 | ||
| Pathology of the spinal cord of C57BL/6J mice infected with rabies virus (CVS-11 strain). | Q45385486 | ||
| Inflammatory responses in the nervous system of mice infected with a street isolate of rabies virus. | Q45393367 | ||
| Apoptosis and rabies virus neuroinvasion. | Q45710584 | ||
| Absence of the p55 Kd TNF-alpha receptor promotes survival in rabies virus acute encephalitis | Q45738739 | ||
| Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence | Q46064734 | ||
| Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination | Q46118529 | ||
| The CARMA3-Bcl10-MALT1 Signalosome Drives NF-κB Activation and Promotes Aggressiveness in Angiotensin II Receptor-positive Breast Cancer | Q47233799 | ||
| MALT1 controls attenuated rabies virus by inducing early inflammation and T cell activation in the brain. | Q47549174 | ||
| Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures | Q47973688 | ||
| MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling | Q48103382 | ||
| The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition. | Q49852317 | ||
| Role of Malt1 protease activity in pathogenesis of inflammatory disorders mediated by FcγR signaling | Q50134625 | ||
| The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling. | Q52878989 | ||
| Activation of microglial cells by beta-amyloid protein and interferon-gamma. | Q53202007 | ||
| Borna disease. An immunopathologic response to viral infection in the CNS | Q67997441 | ||
| Furious and paralytic rabies of canine origin: neuroimaging with virological and cytokine studies | Q81176782 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rabies | Q39222 |
| immunology | Q101929 | ||
| rabies virus | Q698976 | ||
| neuronitis | Q17157137 | ||
| P577 | publication date | 2018-08-29 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Inhibition of MALT1 decreases neuroinflammation and pathogenicity of virulent rabies virus in mice | |
| P478 | volume | 92 |
| Q93047664 | MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner |
| Q60924644 | Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function |
| Q91808429 | Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines |
| Q89899084 | The dual role of TLR7 in the pathogenesis of rabies virus in a mouse model |
Search more.